These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 38640870

  • 1. Structure optimizing of flavonoids against both MRSA and VRE.
    Wei MZ, Zhu YY, Zu WB, Wang H, Bai LY, Zhou ZS, Zhao YL, Wang ZJ, Luo XD.
    Eur J Med Chem; 2024 May 05; 271():116401. PubMed ID: 38640870
    [Abstract] [Full Text] [Related]

  • 2. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR, Yim J, Raut A, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Apr 05; 60(4):2352-8. PubMed ID: 26833159
    [Abstract] [Full Text] [Related]

  • 3. New resorcylic acid derivatives of Lysimachia tengyuehensis against MRSA and VRE by interfering with bacterial metabolic imbalance.
    Shi N, Wang ZJ, Shi YZ, Jiang L, Zhu YY, He XC, Zhou ZS, Wei MZ, Zhao YL, Luo XD.
    Eur J Med Chem; 2024 Nov 05; 277():116714. PubMed ID: 39096819
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017.
    Huang L, Zhang R, Hu Y, Zhou H, Cao J, Lv H, Chen S, Ding S, Chen G.
    Antimicrob Resist Infect Control; 2019 Nov 05; 8():90. PubMed ID: 31164979
    [Abstract] [Full Text] [Related]

  • 5. Ursoricin, a bacteriocin of Streptococcus ursoris, has potent activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Wang C, Le MN-T, Kawada-Matsuo M, Hisatsune J, Sugawara Y, Arai C, Nakanishi J, Takeda K, Shiba H, Sugai M, Komatsuzawa H.
    Appl Environ Microbiol; 2024 Jun 18; 90(6):e0016224. PubMed ID: 38775468
    [Abstract] [Full Text] [Related]

  • 6. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
    Sharma M, Manhas RK.
    BMC Microbiol; 2019 Feb 19; 19(1):44. PubMed ID: 30782119
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
    Shahin IG, Abutaleb NS, Alhashimi M, Kassab AE, Mohamed KO, Taher AT, Seleem MN, Mayhoub AS.
    Eur J Med Chem; 2020 Sep 15; 202():112497. PubMed ID: 32707373
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species.
    Zhang XM, Guo H, Li ZS, Song FH, Wang WM, Dai HQ, Zhang LX, Wang JG.
    Eur J Med Chem; 2015 Aug 28; 101():419-30. PubMed ID: 26185006
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z, Cao B, Liu YM, Gu L, Wang C.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa.
    Zhao LY, Liu HX, Wang L, Xu ZF, Tan HB, Qiu SX.
    J Ethnopharmacol; 2019 Jan 10; 228():50-57. PubMed ID: 30195566
    [Abstract] [Full Text] [Related]

  • 15. Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo.
    Parmar A, Lakshminarayanan R, Iyer A, Mayandi V, Leng Goh ET, Lloyd DG, Chalasani MLS, Verma NK, Prior SH, Beuerman RW, Madder A, Taylor EJ, Singh I.
    J Med Chem; 2018 Mar 08; 61(5):2009-2017. PubMed ID: 29363971
    [Abstract] [Full Text] [Related]

  • 16. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G, Derbentli S.
    Mikrobiyol Bul; 2014 Jan 08; 48(1):123-8. PubMed ID: 24506722
    [Abstract] [Full Text] [Related]

  • 17. Antibacterial activity of 3-methylbenzo[d]thiazol-methylquinolinium derivatives and study of their action mechanism.
    Sun N, Du RL, Zheng YY, Guo Q, Cai SY, Liu ZH, Fang ZY, Yuan WC, Liu T, Li XM, Lu YJ, Wong KY.
    J Enzyme Inhib Med Chem; 2018 Dec 08; 33(1):879-889. PubMed ID: 29722581
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antimicrobial Constituents from Machaerium Pers.: Inhibitory Activities and Synergism of Machaeriols and Machaeridiols against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus faecium, and Permeabilized Gram-Negative Pathogens.
    Muhammad I, Jacob MR, Ibrahim MA, Raman V, Kumarihamy M, Wang M, Al-Adhami T, Hind C, Clifford M, Martin B, Zhao J, Sutton JM, Rahman KM.
    Molecules; 2020 Dec 18; 25(24):. PubMed ID: 33352963
    [Abstract] [Full Text] [Related]

  • 20. Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA.
    Liu X, Tashiro S, Igarashi Y, Takemura W, Kojima N, Morita T, Hayashi M, Enoki Y, Taguchi K, Matsumoto K.
    Pharm Res; 2023 Jan 18; 40(1):187-196. PubMed ID: 36329373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.